$1.12
-0.03-2.61%
At close: -
$1.12
0.000.00%
After Hours: 4:00 PM EDT
Actinium Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Actinium Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.37 | $-0.36 | -2.78 % |
Q2 | 2024-08-05 | $-0.38 | $-0.40 | 5.00 % |
Q1 | 2024-04-26 | $-0.31 | $-0.52 | 40.4 % |
Q4 | 2024-03-29 | $-0.33 | $-0.54 | 38.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2023-11-02 | $0 | $570.00K | -100.0 % |
Q4 | 2023-04-03 | $0 | $1.03M | -100.0 % |
Actinium Pharma (ATNM) is scheduled to report earnings on April 25, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.37, which missed the estimate of $-0.36.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.